Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica

European Spine Journal

Volumn 21, Issue 10, 2012, Pages 2079-2084

  Ohtori, Seiji ^a   Miyagi, Masayuki ^a   Eguchi, Yawara ^a   Inoue, Gen ^a   Orita, Sumihisa ^a   Ochiai, Nobuyasu ^a   Kishida, Shunji ^a   Kuniyoshi, Kazuki ^a   Nakamura, Junichi ^a   Aoki, Yasuchika ^a   Ishikawa, Tetsuhiro ^a   Arai, Gen ^a   Kamoda, Hiroto ^a   Suzuki, Miyako ^a   Takaso, Masashi ^a   Furuya, Takeo ^a   Kubota, Gou ^a   Sakuma, Yoshihiro ^a   Oikawa, Yasuhiro ^a   Toyone, Tomoaki ^a   Takahashi, Kazuhisa ^a   more..

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Anti interleukin 6 receptor monoclonal antibody; Lumbar spinal stenosis; Pain; Sciatica; Tocilizumab

Indexed keywords

DEXAMETHASONE; LIDOCAINE; TOCILIZUMAB;

ADULT; AGED; ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; ISCHIALGIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; SPINAL NERVE;

AGED; AGED, 80 AND OVER; ANALGESIA, EPIDURAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PAIN MEASUREMENT; RECEPTORS, INTERLEUKIN-6; SCIATICA; SPINAL NERVES; SPINAL STENOSIS;

EID: 84868142444     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-012-2183-5     Document Type: Article

References (25)

1. Buenaventura RM, Datta S, Abdi S, Smith HS (2009) Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 12:233-251 (review)
2. Cohen SP, Bogduk N, Dragovich A, Buckenmaier CC 3rd, Griffith S, Kurihara C, Raymond J, Richter PJ, Williams N, Yaksh TL (2009) Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica. Anesthesiology 110:1116-1126
3. Hurri H, Karppinen J (2004) Discogenic pain. Pain 112:225-228
4. Igarashi A, Kikuchi S, Konno S, Olmarker K (2004) Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine 29:2091-2095
5. Ito T, Ohtori S, Inoue G, Koshi T, Doya H, Ozawa T, Saito T, Moriya H, Takahashi K (2007) Glial phosphorylated p38 MAP kinase mediates pain in a rat model of lumbar disc herniation and induces motor dysfunction in a rat model of lumbar spinal canal stenosis. Spine 32:159-167
6. Kishimoto T (2006) Interleukin-6: Discovery of a pleiotropic cytokine. Arthritis Res Ther 8(Suppl 2):S2
7. Konno S, Yabuki S, Sato K, Olmarker K, Kikuchi S (1995)Amodel for acute, chronic, and delayed graded compression of the dog cauda equina: Presentation of the gross, microscopic, and vascular anatomy of the dog cauda equina and accuracy in pressure transmission of the compression model. Spine 20:2758-2764
8. Korhonen T, Karppinen J, Malmivaara A, Autio R, Niinimäki J, Paimela L, Kyllönen E, Lindgren KA, Tervonen O, Seitsalo S, Hurri H (2004) Efficacy of infliximab for disc herniation-induced sciatica: One-year follow-up. Spine 29:2115-2119
9. Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Järvinen S, Niinimäki J, Veeger N, Seitsalo S, Hurri H (2005) The treatment of disc herniation-induced sciatica with infliximab: Results of a randomized, controlled, 3-month followup study. Spine 30:2724-2728
10. Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Bowman C, Hammond A, Kirkham B, Järvinen S, Niinimäki J, Veeger N, Haapea M, Torkki M, Tervonen O, Seitsalo S, Hurri H (2006) The treatment of disc-herniation-induced sciatica with infliximab: One-year follow-up results of FIRST II, a randomized controlled trial. Spine 31:2759-2766
11. Mihara M, Kasutani K, Okazaki M, Nakamura A, Kawai S, Sugimoto M, Matsumoto Y, Ohsugi Y (2005) Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Int Immunopharmacol 5:1731-1740
12. Myers RR, Wagner R, Sorkin LS (1999) Hyperalgesic actions of cytokines on peripheral nerves. In: Watkins LR, Maier SF (eds) Cytokines and pain. Birkhauser, Basel, pp 133-157
13. Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, Kishimoto T (2009) Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): Significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod Rheumatol 19:12-19
14. Noponen-Hietala N, Virtanen I, Karttunen R, Schwenke S, Jakkula E, Li H, Merikivi R, Barral S, Ott J, Karppinen J, Ala-Kokko L (2005) Genetic variations in IL6 associate with intervertebral disc disease characterized by sciatica. Pain 114:186-194
15. Ohtori S, Suzuki M, Koshi T, Takaso M, Yamashita M, Inoue G, Yamauchi K, Orita S, Eguchi Y, Kuniyoshi K, Ochiai N, Kishida S, Nakamura J, Aoki Y, Ishikawa T, Arai G, Miyagi M, Kamoda H, Suzuki M, Toyone T, Takahashi K (2011) Proinflammatory cytokines in the cerebrospinal fluid of patients with lumbar radiculopathy. Eur Spine J 20:942-946
16. Ohtori S, Miyagi M, Eguchi Y, Inoue G, Orita S, Ochiai N, Kishida S, Kuniyoshi K, Nakamura J, Aoki Y, Ishikawa T, Arai G, Kamoda H, Suzuki M, Takaso M, Furuya T, Toyone T, Takahashi K (2011) Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: A prospective randomized study. Spine (Epub ahead of print)
17. Olmarker K, Rydevik B, Nordborg C (1993) Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 18:1425-1432
18. Olmarker K, Larsson K (1998) Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine 23:2538-2544
19. Olmarker K, Nutu M, Størkson R (2003) Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition. Spine 28:1635-1642
20. Onda A, Murata Y, Rydevik B, Larsson K, Kikuchi S, Olmarker K (2004) Infliximab attenuates immunoreactivity of brain-derived neurotrophic factor in a rat model of herniated nucleus pulposus. Spine 29:1857-1861
21. Ozaktay AC, Kallakuri S, Takebayashi T, Cavanaugh JM, Asik I, DeLeo JA, Weinstein JN (2006) Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 15:1529-1537
22. Pocock SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115
23. Riew KD, Yin Y, Gilula L, Bridwell KH, Lenke LG, Lauryssen C, Goette K (2000) The effect of nerve root injections on the need for operative treatment of lumbar radicular pain. J Bone Jt Surg Am 82A:1589-1593
24. Sekiguchi M, Kikuchi S, Myers RR (2004) Experimental spinal stenosis: Relationship between degree of cauda equina compression, neuropathology, and pain. Spine 29:1105-1111
25. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, OPTION Investigators (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): A double-blind, placebocontrolled, randomised trial. Lancet 371:987-997